Evaluation of the Efficacy of Azithromycin in Idiopathic Purulent Oedematous Sinusitis in Adults

PHASE3RecruitingINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

November 21, 2022

Primary Completion Date

November 21, 2027

Study Completion Date

November 21, 2027

Conditions
Sinusitis, ChronicSinus Infection Chronic
Interventions
DRUG

Azithromycin Oral Tablet

Treatment assigned by randomization will be prescribed immediately. The active or placebo will be dispensed by the centre's pharmacy. Treatment will be taken in the morning or evening for 3 months.

DRUG

Placebo

Treatment assigned by randomization will be prescribed immediately. The active or placebo will be dispensed by the centre's pharmacy. Treatment will be taken in the morning or evening for 3 months.

Trial Locations (13)

13005

RECRUITING

Hôpitaux Universitaires de Marseille Conception, Marseille

44093

RECRUITING

Centre Hospitalier Universitaire De Nantes, Nantes

59000

RECRUITING

CHU Lille, Lille

75010

RECRUITING

Hôpital Lariboisiere, Paris

94000

RECRUITING

Centre Hospitalier Intercommunal, Créteil

94010

RECRUITING

Hôpital Henri Mondor, Créteil

Unknown

NOT_YET_RECRUITING

CHU Bordeaux, Bordeaux

RECRUITING

CHU Bicêtre, AP-HP, Le Kremlin-Bicêtre

RECRUITING

CHU de la Croix Rousse, Lyon

RECRUITING

Hospices de Lyon, Lyon

RECRUITING

CHRU de Nancy, Nancy

NOT_YET_RECRUITING

CHU Cochin, Paris

NOT_YET_RECRUITING

CHU Toulouse, Toulouse

All Listed Sponsors
lead

Centre Hospitalier Intercommunal Creteil

OTHER